Page last updated: 2024-11-01

o(6)-benzylguanine and Kahler Disease

o(6)-benzylguanine has been researched along with Kahler Disease in 1 studies

O(6)-benzylguanine: a suicide inhibitor of O(6)-methylguanine-DNA methyltransferase activity

Research Excerpts

ExcerptRelevanceReference
"Carmustine (BCNU) is known to have modest activity in multiple myeloma; however, resistance to BCNU manifests by the activity of O6-methylguanine methyltransferase (MGMT)."9.12O6-benzylguanine and BCNU in multiple myeloma: a phase II trial. ( Bahlis, N; Batts, ED; Fu, P; Gerson, SL; Kane, D; Liu, L; Maisel, C; O'Brien, T; Remick, S, 2007)
"Carmustine (BCNU) is known to have modest activity in multiple myeloma; however, resistance to BCNU manifests by the activity of O6-methylguanine methyltransferase (MGMT)."5.12O6-benzylguanine and BCNU in multiple myeloma: a phase II trial. ( Bahlis, N; Batts, ED; Fu, P; Gerson, SL; Kane, D; Liu, L; Maisel, C; O'Brien, T; Remick, S, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batts, ED1
Maisel, C1
Kane, D1
Liu, L1
Fu, P1
O'Brien, T1
Remick, S1
Bahlis, N1
Gerson, SL1

Trials

1 trial available for o(6)-benzylguanine and Kahler Disease

ArticleYear
O6-benzylguanine and BCNU in multiple myeloma: a phase II trial.
    Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; DNA; Drug Administration Sc

2007